Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | Institution | 1.153.496 | 8,04% | US$ 161,85M | 2026-03-31 |
| First Light Asset Management, LLC | Institution | 980.758 | 6,84% | US$ 137,61M | 2026-03-31 |
| BVF Partners L.P. | Institution | 960.989 | 6,70% | US$ 134,84M | 2026-03-31 |
| Frazier Life Sciences Management, LP | Institution | 882.400 | 6,15% | US$ 123,81M | 2026-03-31 |
| Averill Master Fund, Ltd. | Institution | 714.463 | 4,98% | US$ 100,25M | 2025-09-30 |
| BlackRock, Inc. | Institution | 686.853 | 4,79% | US$ 96,37M | 2026-03-31 |
| Samsara Biocapital, L.P. | Institution | 679.486 | 4,74% | US$ 95,34M | 2024-12-20 |
| Jennison Associates LLC | Institution | 640.611 | 4,47% | US$ 89,88M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 471.202 | 3,29% | US$ 66,11M | 2025-12-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 440.575 | 3,07% | US$ 61,82M | 2024-12-13 |
| Federated Hermes, Inc. | Institution | 433.015 | 3,02% | US$ 60,76M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 402.564 | 2,81% | US$ 56,48M | 2026-03-31 |
| Frontier Capital Management Co LLC | Institution | 374.035 | 2,61% | US$ 52,48M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 341.883 | 2,38% | US$ 47,97M | 2025-12-31 |
| Woodline Partners LP | Institution | 317.517 | 2,21% | US$ 44,55M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 267.320 | 1,86% | US$ 37,51M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 262.835 | 1,83% | US$ 36,88M | 2026-03-31 |
| Artal Group S.A. | Institution | 257.485 | 1,80% | US$ 36,13M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 233.248 | 1,63% | US$ 32,73M | 2026-03-31 |
| FMR LLC | Institution | 215.774 | 1,50% | US$ 30,28M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 206.404 | 1,44% | US$ 28,96M | 2026-03-31 |
| PRIMECAP Management Company | Institution | 195.030 | 1,36% | US$ 27,36M | 2026-03-31 |
| Artisan Partners Limited Partnership | Institution | 193.796 | 1,35% | US$ 27,19M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 186.031 | 1,30% | US$ 26,10M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 179.922 | 1,25% | US$ 25,24M | 2026-03-31 |
| UBS Asset Management AG | Institution | 174.438 | 1,22% | US$ 24,48M | 2026-03-31 |
| First Turn Management, LLC | Institution | 148.093 | 1,03% | US$ 20,78M | 2026-03-31 |
| Dellora Investments LP | Institution | 141.079 | 0,98% | US$ 19,79M | 2024-12-13 |
| OrbiMed Advisors LLC | Institution | 134.600 | 0,94% | US$ 18,89M | 2026-03-31 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 129.905 | 0,91% | US$ 18,23M | 2024-12-13 |
| Dellora Investments Master Fund LP | Institution | 123.034 | 0,86% | US$ 17,26M | 2024-12-13 |
| Balyasny Asset Management L.P. | Institution | 96.726 | 0,67% | US$ 13,57M | 2026-03-31 |
| Millennium Management LLC | Institution | 93.646 | 0,65% | US$ 13,14M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 90.858 | 0,63% | US$ 12,75M | 2026-03-31 |
| Clio Asset Management LLC | Institution | 90.757 | 0,63% | US$ 12,73M | 2026-03-31 |
| Apis Capital Advisors, LLC | Institution | 89.000 | 0,62% | US$ 12,49M | 2026-03-31 |
| Nextbio Capital Management Lp | Institution | 82.686 | 0,58% | US$ 11,60M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
